Prenetics reports Q2 EPS (94c) vs (88c) last year

Reports Q2 revenue $17.7M vs $2.544M last year. Danny Yeung, Chief Executive Officer and Co-Founder, remarked, “This quarter marks a pivotal moment for Prenetics (PRE) as we demonstrate the successful execution of our strategic vision. The phenomenal growth of IM8, which is on track to achieve an unprecedented $100 million in annual recurring revenue within just our first year of operations, represents a milestone that is virtually unheard of in any industry. With IM8 currently generating $5.9 million in monthly revenue in August, we aim to hit $9 million per month by the end of the year, which would solidify our path to this extraordinary achievement. With such strong growth momentum, we believe we can build IM8 into one of the World’s largest health and wellness brands in the coming years. Beyond the financial metrics, what makes me truly proud is the positive impact IM8 has had on so many people’s health and wellness journeys – with over 8 million servings delivered and more than 300,000 customer orders, we are genuinely making a difference in people’s lives.”